Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

Tian, Jianhua; Teuscher, Kevin B.; Aho, Erin R.; Alvarado, Joseph R.; Mills, Jonathan J.; Meyers, Kenneth M.; Gogliotti, Rocco D.; Han, Changho; Macdonald, Jonathan D.; Sai, Jiqing; Shaw, J. Grace; Sensintaffar, John L.; Zhao, Bin; Rietz, Tyson A.; Thomas, Lance R.; Payne, William G.; Moore, William J.; Stott, Gordon M.; Kondo, Jumpei; Inoue, Masahiro; Coffey, Robert J.; Tansey, William P.; Stauffer, Shaun R.; Lee, Taekyu; Fesik, Stephen W.

doi:10.1021/acs.jmedchem.9b01608

Title: Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

Journal Article · Fri Dec 20 00:00:00 EST 2019 · Journal of Medicinal Chemistry

DOI:https://doi.org/10.1021/acs.jmedchem.9b01608· OSTI ID:1598029

Tian, Jianhua ^[1]; Teuscher, Kevin B. ^[1]; Aho, Erin R. ^[1]; Alvarado, Joseph R. ^[1];

^[1]; Meyers, Kenneth M. ^[1]; Gogliotti, Rocco D. ^[1]; Han, Changho ^[1]; Macdonald, Jonathan D. ^[1]; Sai, Jiqing ^[1]; Shaw, J. Grace ^[1]; Sensintaffar, John L. ^[1]; Zhao, Bin ^[1]; Rietz, Tyson A. ^[1]; Thomas, Lance R. ^[1]; Payne, William G. ^[1]; Moore, William J. ^[2]; Stott, Gordon M. ^[2]; Kondo, Jumpei ^[3]; Inoue, Masahiro ^[3] more »

Vanderbilt Univ., Nashville, TN (United States)
Frederick National Lab. for Cancer Research, MD (United States)
Kyoto Univ. (Japan); Osaka International Cancer Inst. (Japan)

WD repeat domain 5 (WDR5) is a member of the WD40-repeat protein family that plays a critical role in multiple chromatin-centric processes. Overexpression of WDR5 correlates with a poor clinical outcome in many human cancers, and WDR5 itself has emerged as an attractive target for therapy. Most drug-discovery efforts center on the WIN site of WDR5 that is responsible for the recruitment of WDR5 to chromatin. In this paper, we describe discovery of a novel WDR5 WIN site antagonists containing a dihydroisoquinolinone bicyclic core using a structure-based design. These compounds exhibit picomolar binding affinity and selective concentration-dependent antiproliferative activities in sensitive MLL-fusion cell lines. Furthermore, these WDR5 WIN site binders inhibit proliferation in MYC-driven cancer cells and reduce MYC recruitment to chromatin at MYC/WDR5 co-bound genes. Thus, these molecules are useful probes to study the implication of WDR5 inhibition in cancers and serve as a potential starting point toward the discovery of anti-WDR5 therapeutics.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: National Institutes of Health (NIH); National Cancer Institute (NCI); USDOE Office of Science (SC); Michigan Economic Development Corporation and Michigan Technology Tri-Corridor

Grant/Contract Number:: 1S-10RR025677-01; AC02-06CH11357; 085P1000817; CA211305

OSTI ID:: 1598029

Journal Information:: Journal of Medicinal Chemistry, Vol. 63, Issue 2; ISSN 0022-2623

Publisher:: American Chemical Society (ACS)Copyright Statement

Country of Publication:: United States

Language:: ENGLISH

Citation Metrics:

Cited by: 17 works

Citation information provided by
Web of Science

References (37)

WD40 proteins propel cellular networks Stirnimann, Christian U.; Petsalaki, Evangelia; Russell, Robert B. Trends in Biochemical Sciences, Vol. 35, Issue 10 https://doi.org/10.1016/j.tibs.2010.04.003	journal	October 2010
Structure and function of WD40 domain proteins Xu, Chao; Min, Jinrong Protein & Cell, Vol. 2, Issue 3 https://doi.org/10.1007/s13238-011-1018-1	journal	March 2011
Moonlighting with WDR5: A Cellular Multitasker Guarnaccia, Alissa; Tansey, William Journal of Clinical Medicine, Vol. 7, Issue 2 https://doi.org/10.3390/jcm7020021	journal	January 2018
WDR5 Expression Is Prognostic of Breast Cancer Outcome Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun PLOS ONE, Vol. 10, Issue 9 https://doi.org/10.1371/journal.pone.0124964	journal	September 2015
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth Zhu, Jiajun; Sammons, Morgan A.; Donahue, Greg Nature, Vol. 525, Issue 7568 https://doi.org/10.1038/nature15251	journal	September 2015
Discovery of Potent 2-Aryl-6,7-dihydro-5 H -pyrrolo[1,2- a ]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design Wang, Feng; Jeon, Kyu Ok; Salovich, James M. Journal of Medicinal Chemistry, Vol. 61, Issue 13 https://doi.org/10.1021/acs.jmedchem.8b00375	journal	June 2018
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity Aho, Erin R.; Wang, Jing; Gogliotti, Rocco D. Cell Reports, Vol. 26, Issue 11 https://doi.org/10.1016/j.celrep.2019.02.047	journal	March 2019
A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian Journal of Biological Chemistry, Vol. 283, Issue 47 https://doi.org/10.1074/jbc.m806317200	journal	October 2008
MLL: a histone methyltransferase disrupted in leukemia Hess, Jay L. Trends in Molecular Medicine, Vol. 10, Issue 10 https://doi.org/10.1016/j.molmed.2004.08.005	journal	October 2004
Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes Alicea-Velázquez, Nilda L.; Shinsky, Stephen A.; Loh, Daniel M. Journal of Biological Chemistry, Vol. 291, Issue 43 https://doi.org/10.1074/jbc.m116.752626	journal	August 2016
Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC Thomas, Lance R.; Wang, Qingguo; Grieb, Brian C. Molecular Cell, Vol. 58, Issue 3 https://doi.org/10.1016/j.molcel.2015.02.028	journal	May 2015
Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation Chen, Xu; Xie, Weibin; Gu, Peng Scientific Reports, Vol. 5, Issue 1 https://doi.org/10.1038/srep08293	journal	February 2015
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer Carugo, Alessandro; Genovese, Giannicola; Seth, Sahil Cell Reports, Vol. 16, Issue 1 https://doi.org/10.1016/j.celrep.2016.05.063	journal	June 2016
PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407 Tan, Xin; Chen, Shuai; Wu, Jiangxue Cell Death & Disease, Vol. 8, Issue 3 https://doi.org/10.1038/cddis.2017.111	journal	March 2017
Up‐regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression Sun, Wei; Guo, Fuchao; Liu, Mingkai Journal of Cellular Biochemistry, Vol. 119, Issue 4 https://doi.org/10.1002/jcb.26491	journal	December 2017
A Twist1-MLL-WDR5-HOTTIP Complex Regulates HOXA9 Chromatin to Facilitate Metastasis of Prostate Cancer Tran, P. T.; Gajula, R.; Williams, R. International Journal of Radiation OncologyBiologyPhysics, Vol. 90, Issue 1 https://doi.org/10.1016/j.ijrobp.2014.05.691	journal	September 2014
Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma Wu, Yaping; Diao, Pengfei; Li, Zhongwu Journal of Oral Pathology & Medicine, Vol. 47, Issue 5 https://doi.org/10.1111/jop.12708	journal	April 2018
WDR5 high expression and its effect on tumorigenesis in leukemia Ge, Zheng; Song, Evelyn J.; Kawasawa, Yuka Imamura Oncotarget, Vol. 7, Issue 25 https://doi.org/10.18632/oncotarget.9312	journal	May 2016
The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer Lu, Kebin; Tao, He; Si, Xiaomin Frontiers in Oncology, Vol. 8 https://doi.org/10.3389/fonc.2018.00502	journal	November 2018
The MLL recombinome of acute leukemias in 2013 Meyer, C.; Hofmann, J.; Burmeister, T. Leukemia, Vol. 27, Issue 11 https://doi.org/10.1038/leu.2013.135	journal	April 2013
The Pathogenesis of Mixed-Lineage Leukemia Muntean, Andrew G.; Hess, Jay L. Annual Review of Pathology: Mechanisms of Disease, Vol. 7, Issue 1 https://doi.org/10.1146/annurev-pathol-011811-132434	journal	February 2012
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches Winters, Amanda C.; Bernt, Kathrin M. Frontiers in Pediatrics, Vol. 5 https://doi.org/10.3389/fped.2017.00004	journal	February 2017
MLL translocations, histone modifications and leukaemia stem-cell development Krivtsov, Andrei V.; Armstrong, Scott A. Nature Reviews Cancer, Vol. 7, Issue 11 https://doi.org/10.1038/nrc2253	journal	November 2007
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia Cao, Fang; Townsend, Elizabeth C.; Karatas, Hacer Molecular Cell, Vol. 53, Issue 2 https://doi.org/10.1016/j.molcel.2013.12.001	journal	January 2014
MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia Chen, Yufei; Anastassiadis, Konstantinos; Kranz, Andrea Cancer Cell, Vol. 31, Issue 6 https://doi.org/10.1016/j.ccell.2017.05.002	journal	June 2017
Targeting WDR5: A WINning Anti-Cancer Strategy? Aho, Erin R.; Weissmiller, April M.; Fesik, Stephen W. Epigenetics Insights, Vol. 12 https://doi.org/10.1177/2516865719865282	journal	January 2019
Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction Karatas, Hacer; Li, Yangbing; Liu, Liu Journal of Medicinal Chemistry, Vol. 60, Issue 12 https://doi.org/10.1021/acs.jmedchem.6b01796	journal	June 2017
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia Grebien, Florian; Vedadi, Masoud; Getlik, Matthäus Nature Chemical Biology, Vol. 11, Issue 8 https://doi.org/10.1038/nchembio.1859	journal	July 2015
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1) Getlik, Matthäus; Smil, David; Zepeda-Velázquez, Carlos Journal of Medicinal Chemistry, Vol. 59, Issue 6 https://doi.org/10.1021/acs.jmedchem.5b01630	journal	March 2016
Analysis of the Binding of Mixed Lineage Leukemia 1 (MLL1) and Histone 3 Peptides to WD Repeat Domain 5 (WDR5) for the Design of Inhibitors of the MLL1−WDR5 Interaction Karatas, Hacer; Townsend, Elizabeth C.; Bernard, Denzil Journal of Medicinal Chemistry, Vol. 53, Issue 14 https://doi.org/10.1021/jm100139b	journal	July 2010
Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer Kondo, J.; Endo, H.; Okuyama, H. Proceedings of the National Academy of Sciences, Vol. 108, Issue 15 https://doi.org/10.1073/pnas.1015938108	journal	March 2011
High-throughput screening in colorectal cancer tissue-originated spheroids Kondo, Jumpei; Ekawa, Tomoya; Endo, Hiroko Cancer Science, Vol. 110, Issue 1 https://doi.org/10.1111/cas.13843	journal	November 2018
Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT) Yang, Hongfang; Medeiros, Patricia F.; Raha, Kaushik ACS Medicinal Chemistry Letters, Vol. 6, Issue 5 https://doi.org/10.1021/acsmedchemlett.5b00025	journal	April 2015
The Myc oncoprotein as a therapeutic target for human cancer Vita, Marina; Henriksson, Marie Seminars in Cancer Biology, Vol. 16, Issue 4 https://doi.org/10.1016/j.semcancer.2006.07.015	journal	August 2006
MYC as a regulator of ribosome biogenesis and protein synthesis van Riggelen, Jan; Yetil, Alper; Felsher, Dean W. Nature Reviews Cancer, Vol. 10, Issue 4 https://doi.org/10.1038/nrc2819	journal	April 2010
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang Analytical Biochemistry, Vol. 332, Issue 2 https://doi.org/10.1016/j.ab.2004.05.055	journal	September 2004
Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine Methyltransferases Ferry, Joseph J.; Smith, Robert F.; Denney, Natalie ASSAY and Drug Development Technologies, Vol. 13, Issue 4 https://doi.org/10.1089/adt.2015.646	journal	May 2015

Similar Records

Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

Journal Article · Fri Mar 01 00:00:00 EST 2019 · Cell Reports · OSTI ID:1598029

Aho, Erin R.; Wang, Jing; Gogliotti, Rocco D.; +22 more

Discovery of Potent 2-Aryl-6,7-dihydro-5$H$-pyrrolo[1,2-$a$]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design

Journal Article · Mon Jun 11 00:00:00 EDT 2018 · Journal of Medicinal Chemistry · OSTI ID:1598029

Wang, Feng; Jeon, Kyu Ok; Salovich, James M.; +15 more

A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models

Journal Article · Wed Sep 29 00:00:00 EDT 2021 · Science Translational Medicine · OSTI ID:1598029

Yu, Xufen; Li, Dongxu; Kottur, Jithesh; +16 more

Related Subjects

60 APPLIED LIFE SCIENCES
Cells
Inhibitors
Cancer
Peptides and proteins
Genetics

Title: Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

Citation Formats

References (37)

Similar Records

Related Subjects